News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,791 Results
Type
Article (40154)
Company Profile (284)
Press Release (649353)
Section
Business (205967)
Career Advice (2033)
Deals (35562)
Drug Delivery (86)
Drug Development (81247)
Employer Resources (172)
FDA (16179)
Job Trends (14897)
News (347441)
Policy (32648)
Tag
Academia (2585)
Alliances (49496)
Alzheimer's disease (1224)
Approvals (16098)
Artificial intelligence (117)
Bankruptcy (355)
Best Places to Work (11514)
Biotechnology (203)
Breast cancer (109)
Cancer (909)
Cardiovascular disease (82)
Career advice (1696)
Cell therapy (200)
Clinical research (64273)
Collaboration (334)
Compensation (171)
COVID-19 (2549)
Cystic fibrosis (79)
Data (869)
Diabetes (136)
Diagnostics (6166)
Earnings (85259)
Employer resources (147)
Events (109785)
Executive appointments (249)
FDA (16629)
Funding (294)
Gene therapy (153)
GLP-1 (566)
Government (4350)
Healthcare (18782)
Infectious disease (2624)
Inflammatory bowel disease (102)
Interviews (319)
IPO (16383)
Job creations (3679)
Job search strategy (1447)
Layoffs (416)
Legal (7882)
Lung cancer (154)
Manufacturing (154)
Medical device (13230)
Medtech (13235)
Mergers & acquisitions (19197)
Metabolic disorders (369)
Neuroscience (1469)
NextGen Class of 2024 (6539)
Non-profit (4495)
Northern California (1212)
Obesity (217)
Opinion (180)
Patents (94)
People (56543)
Phase I (19938)
Phase II (28317)
Phase III (21131)
Pipeline (215)
Postmarket research (2561)
Preclinical (8480)
Radiopharmaceuticals (235)
Rare diseases (181)
Real estate (5966)
Regulatory (21607)
Research institute (2354)
Resumes & cover letters (355)
Southern California (1093)
Startups (3609)
United States (11731)
Vaccines (544)
Weight loss (164)
Date
Today (211)
Last 7 days (850)
Last 30 days (2936)
Last 365 days (36078)
2024 (30631)
2023 (40329)
2022 (51428)
2021 (56013)
2020 (54406)
2019 (46846)
2018 (35299)
2017 (32499)
2016 (31863)
2015 (37959)
2014 (31669)
2013 (26746)
2012 (28893)
2011 (29581)
2010 (27720)
Location
Africa (726)
Arizona (187)
Asia (37670)
Australia (6195)
California (2748)
Canada (1178)
China (210)
Colorado (118)
Connecticut (124)
Europe (81021)
Florida (394)
Georgia (100)
Illinois (307)
Indiana (181)
Kansas (95)
Maryland (519)
Massachusetts (2238)
Michigan (143)
Minnesota (253)
New Jersey (834)
New York (842)
North Carolina (665)
Northern California (1212)
Ohio (127)
Pennsylvania (749)
South America (1109)
Southern California (1093)
Texas (385)
Utah (80)
Washington State (322)
689,791 Results for "q biomed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Q BioMed Inc. Provides Update to Shareholders - June 23, 2023
Q BioMed Inc. provides an update to shareholders.
June 23, 2023
·
3 min read
Business
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update.
May 13, 2024
·
13 min read
Pharm Country
Orchestra BioMed to Participate in Jefferies 2024 Global Healthcare Conference
Orchestra BioMed Holdings, Inc. announced that company management will present and be available for one-on-one meetings at the Jefferies Global Healthcare Conference being held in New York, NY, June 4-6, 2024.
May 22, 2024
·
1 min read
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Policy
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced the patent estate related to AVIM Therapy has reached 110 patents worldwide.
April 30, 2024
·
8 min read
Pharm Country
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced further details on its in-person R&D day at the Lotte New York Palace Hotel on Tuesday, June 11, 2024, at 10:00 AM ET.
June 4, 2024
·
6 min read
Business
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial results and provided a fourth quarter business update.
March 27, 2024
·
13 min read
Business
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced the appointment of David Pacitti to its Board of Directors, effective as of March 26, 2024.
March 26, 2024
·
7 min read
Policy
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.
June 4, 2024
·
1 min read
Pharm Country
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced two oral presentations were given at the Cardiovascular Research Technologies (“CRT”) 2024 Meeting in Washington, D.C.
March 13, 2024
·
9 min read
1 of 68,980
Next
